Orchestra BioMed Holdings, Inc. Quarterly Current Ratio in % from Q2 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Orchestra BioMed Holdings, Inc. quarterly Current Ratio history and growth rate from Q2 2021 to Q3 2024.
  • Orchestra BioMed Holdings, Inc. Current Ratio for the quarter ending September 30, 2024 was 574 %, a 17.4% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 574 -121 -17.4% Sep 30, 2024
Q2 2024 594 -169 -22.1% Jun 30, 2024
Q1 2024 719 +65.6 +10% Mar 31, 2024
Q4 2023 793 +380 +92.1% Dec 31, 2023
Q3 2023 695 +512 +280% Sep 30, 2023
Q2 2023 763 +382 +100% Jun 30, 2023
Q1 2023 654 -239 -26.7% Mar 31, 2023
Q4 2022 413 -745 -64.3% Dec 31, 2022
Q3 2022 183 -1.12K -85.9% Sep 30, 2022
Q2 2022 381 -1.13K -74.8% Jun 30, 2022
Q1 2022 892 Mar 31, 2022
Q4 2021 1.16K Dec 31, 2021
Q3 2021 1.3K Sep 30, 2021
Q2 2021 1.51K Jun 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.